Literature DB >> 7493018

A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

C Ho1, D A Conner, M R Pollak, D J Ladd, O Kifor, H B Warren, E M Brown, J G Seidman, C E Seidman.   

Abstract

Mice lacking the calcium-sensing receptor (Casr) were created to examine the receptor's role in calcium homeostasis and to elucidate the mechanism by which inherited human Casr gene defects cause diseases. Casr+/- mice, analogous to humans with familial hypocalciuric hypercalcemia, had benign and modest elevations of serum calcium, magnesium and parathyroid hormone levels as well as hypocalciuria. In contrast, Casr-/- mice, like humans with neonatal severe hyperparathyroidism, had markedly elevated serum calcium and parathyroid hormone levels, parathyroid hyperplasia, bone abnormalities, retarded growth and premature death. Our findings suggest that Casr mutations cause these human disorders by reducing the number of functional receptor molecules on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7493018     DOI: 10.1038/ng1295-389

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  134 in total

Review 1.  Calcium receptor and regulation of parathyroid hormone secretion.

Authors:  E M Brown
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  The hunting of the snark: the elusive calcium receptor(s).

Authors:  Lawrence G Raisz
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 3.  Is the calcium receptor a molecular target for the actions of strontium on bone?

Authors:  Edward M Brown
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

4.  Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.

Authors:  Melita M Dvorak-Ewell; Tsui-Hua Chen; Nathan Liang; Caitlin Garvey; Betty Liu; Chialing Tu; Wenhan Chang; Daniel D Bikle; Dolores M Shoback
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

5.  Extracellular calcium sensing receptor stimulation in human colonic epithelial cells induces intracellular calcium oscillations and proliferation inhibition.

Authors:  Osvaldo Rey; Steven H Young; Rodrigo Jacamo; Mary P Moyer; Enrique Rozengurt
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

6.  The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.

Authors:  Yingben Xue; Yongjun Xiao; Jingning Liu; Andrew C Karaplis; Martin R Pollak; Edward M Brown; Dengshun Miao; David Goltzman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

7.  Allosteric modulation of the calcium-sensing receptor by gamma-glutamyl peptides: inhibition of PTH secretion, suppression of intracellular cAMP levels, and a common mechanism of action with L-amino acids.

Authors:  Geoffrey K Broadhead; Hee-chang Mun; Vimesh A Avlani; Orane Jourdon; W Bret Church; Arthur Christopoulos; Leigh Delbridge; Arthur D Conigrave
Journal:  J Biol Chem       Date:  2010-12-27       Impact factor: 5.157

8.  Assessing constitutive activity of extracellular calcium-sensing receptors in vitro and in bone.

Authors:  Wenhan Chang; Melita Dvorak; Dolores Shoback
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

9.  Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6.

Authors:  Thaddeus P Dryja; Terri L McGee; Eliot L Berson; Gerald A Fishman; Michael A Sandberg; Kenneth R Alexander; Deborah J Derlacki; Aruna S Rajagopalan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

Review 10.  Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

Authors:  James B Wetmore; L Darryl Quarles
Journal:  Nat Clin Pract Nephrol       Date:  2008-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.